000 01211 a2200325 4500
005 20250514200502.0
264 0 _c20040916
008 200409s 0 0 eng d
022 _a0921-4410
024 7 _a10.1016/s0921-4410(03)21027-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPecorelli, S
245 0 0 _aSystemic therapy for gynecological neoplasms: ovary, cervix and endometrium.
_h[electronic resource]
260 _bCancer chemotherapy and biological response modifiers
_c2003
300 _a565-84 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aEndometrial Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aGenital Neoplasms, Female
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aUterine Cervical Neoplasms
_xdrug therapy
700 1 _aAngioli, R
700 1 _aFavalli, G
700 1 _aOdicino, F
773 0 _tCancer chemotherapy and biological response modifiers
_gvol. 21
_gp. 565-84
856 4 0 _uhttps://doi.org/10.1016/s0921-4410(03)21027-9
_zAvailable from publisher's website
999 _c15035975
_d15035975